GI & Endoscopy

Here are seven news updates for gastroenterologists to know for March 27, 2015.

Here is a stock report on five publicly traded GI/endoscopy companies for March 23 to March 27.

The FDA will host a public meeting to solicit patient input on functional GI disorders on May 11, according to an AGA eDigest report.

In letters dated March 26, Olympus sent updated, validated manual reprocessing instructions for the TJF-Q180V duodenoscopes, according to an EINNEWSDESK report.  

Shire and Cincinnati Children's Hospital Medical Center have created a three-year partnership to focus on developing therapies for rare diseases with unmet need, according to a Genetic Engineering & Biotechnology News report.

Pedro Greer Jr., MD, is a gastroenterologist practicing at Herbert Wertham College of Medicine at Florida International University in Miami, where he is also a professor and the founding chair of the department of humanities, health and society and association…

The competition in the hepatitis C drug market is heating up, with Gilead Sciences and AbbVie controlling most of the market despite Merck's attempts to close the gap, according to a Seeking Alpha report.

The global market for Crohn's disease is expected to grow at a compound annual growth rate of 2.84 percent from 2014 to 2019, according to a Market Research report.  

A number of healthcare stakeholders have pledged to bring the national colorectal cancer screening rate to 80 percent by 2018, but many Americans remain reluctant to undergo one of the key screening procedures: colonoscopy. Here are six statistics on why…

A new study published in the journal Clinical Gastroenterology and Hepatology has found an association between inflammatory bowel disease in women and increased risk of cervical dysplasia and cancer.